|
|
|
Insider
Information: |
Crowley John F |
Relationship: |
Director |
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
590,194 |
|
Indirect Shares
|
97,759 |
|
|
Direct
Value |
$6,353,484 |
|
|
Indirect Value
|
$688,536 |
|
|
Total
Shares |
687,953 |
|
|
Total
Value |
$7,042,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 12 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2023-10-16 |
4 |
S |
$10.50 |
$63,449 |
D/D |
(6,044) |
901,921 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2023-11-15 |
4 |
S |
$10.84 |
$65,497 |
D/D |
(6,043) |
889,834 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2023-12-01 |
4 |
S |
$11.08 |
$66,956 |
D/D |
(6,043) |
883,791 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2023-12-15 |
4 |
S |
$12.66 |
$76,516 |
D/D |
(6,043) |
877,748 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2023-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
34,572 |
912,320 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
144,628 |
1,056,948 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-03 |
4 |
D |
$13.53 |
$1,466,882 |
D/D |
(108,417) |
948,531 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-04 |
4 |
D |
$13.44 |
$143,257 |
D/D |
(10,659) |
937,872 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-09 |
4 |
D |
$13.65 |
$503,207 |
D/D |
(36,865) |
901,007 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-10 |
4 |
S |
$13.65 |
$431,452 |
D/D |
(31,614) |
869,393 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-16 |
4 |
S |
$12.78 |
$404,106 |
D/D |
(31,614) |
837,779 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-22 |
4 |
S |
$12.36 |
$683,958 |
D/D |
(55,327) |
782,452 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-02-01 |
4 |
D |
$12.67 |
$273,621 |
D/D |
(21,596) |
729,242 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-02-01 |
4 |
S |
$12.62 |
$398,918 |
D/D |
(31,614) |
750,838 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-02-15 |
4 |
S |
$13.81 |
$436,551 |
D/D |
(31,614) |
697,628 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-02-15 |
4 |
D |
$14.00 |
$1,329,566 |
D/D |
(94,969) |
602,659 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-03-01 |
4 |
S |
$13.35 |
$389,543 |
D/D |
(29,181) |
573,478 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-09 |
4/A |
D |
$13.65 |
$503,207 |
D/D |
(36,865) |
958,627 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-09 |
4/A |
A |
$0.00 |
$0 |
D/D |
57,620 |
995,492 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
|
2024-01-10 |
4/A |
S |
$13.65 |
$431,452 |
D/D |
(31,614) |
927,013 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2011-12-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
9,867 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2013-12-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
117,925 |
15,484 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2014-12-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
25,584 |
83,499 |
0 |
- |
|
298 Records found
|
|
Page 12 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|